All News #Library
Biotech
Reviva Shares RECOVER Ph3 Data on Schizophrenia Negative Symptoms
08 Jan 2026 //
GLOBENEWSWIRE
Reviva Updates Brilaroxazine Development For Schizophrenia
23 Dec 2025 //
GLOBENEWSWIRE
Reviva To Showcase Brilaroxazine`s Anti-Inflammatory Effects
12 Nov 2025 //
GLOBENEWSWIRE
Reviva Presents Brilaroxazine Ph 3 Schizophrenia Data at CNS 2025
28 Oct 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support